Gut Microbes Take Center Stage in Gastrointestinal Cancer Research
A new commentary synthesizes how gut microbial dysbiosis drives colorectal, gastric, and liver cancer and how microbiome-based diagnostics and therapies ...
A new commentary synthesizes how gut microbial dysbiosis drives colorectal, gastric, and liver cancer and how microbiome-based diagnostics and therapies ...
A new systematic review and meta-analysis of 20 human studies finds no consistent association between root canal bacteria and breast ...
A comprehensive new review details how oral microbial dysbiosis, driven by pathogens like Fusobacterium nucleatum and Porphyromonas gingivalis, is increasingly ...
New research in Nature Microbiology reveals that Fusobacterium nucleatum boosts toxin production by enterotoxigenic Bacteroides fragilis through the metabolite 2-hydroxybutyric ...
A new review details how disruptions in the gastrointestinal microbiome drive cancer through inflammation, genotoxins, and immune evasion, while microbial ...
A comprehensive review details how specific gut microbes and their metabolites shape responses to cancer immunotherapy and chemotherapy, and how ...
A Genome Biology review charts how multi-omics technologies and artificial intelligence are transforming cancer microbiome research from observational associations toward ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine